Literature DB >> 24160730

Treatment of cystic macular lesions in hereditary retinal dystrophies.

Serena Salvatore1, Gerald A Fishman, Mohamed A Genead.   

Abstract

Cystic macular lesions frequently contribute to impaired visual acuity in hereditary retinal dystrophies. Their pathogenesis varies and is not entirely understood. Carbonic anhydrase inhibitors have proven to be potentially efficacious, although not in all cases. We discuss the various factors and mechanisms implicated in the etiology of cystic macular lesions (anatomical abnormalities, impairment of the blood-retinal barrier, tangential vitreous traction, and mutations in retinoschin, etc.) and the various treatments that have been proposed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Goldmann-Favre syndrome; X-linked retinoschisis; choroideremia; cystoid macular lesions; enhanced S-cone syndrome; gyrate atrophy; hereditary retinal dystrophies; retinitis pigmentosa

Mesh:

Substances:

Year:  2013        PMID: 24160730     DOI: 10.1016/j.survophthal.2012.11.006

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  15 in total

1.  Outcomes of Ahmed glaucoma valve implantation for steroid-induced elevated intraocular pressure in patients with retinitis pigmentosa.

Authors:  Umit Eksioglu; Caglar Oktem; Gulten Sungur; Mehmet Yakin; Gulizar Demirok; Firdevs Ornek
Journal:  Int Ophthalmol       Date:  2017-07-21       Impact factor: 2.031

2.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

3.  Long-term rearrangement of retinal structures in a novel mutation of X-linked retinoschisis.

Authors:  Stefano Piermarocchi; Stefania Miotto; Davide Colavito; Elda Del Giudice; Alberta Leon; Veronica Maritan; Rita Piermarocchi; Alma Patrizia Tormene
Journal:  Biomed Rep       Date:  2017-07-27

4.  Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Andrea Sodi; Ilaria Passerini; Dario Giorgio; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-15       Impact factor: 3.117

Review 5.  Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Authors:  Masood Naseripour; Sara Hemmati; Samira Chaibakhsh; Arzhang Gordiz; Leila Miri; Fatemeh Abdi
Journal:  Eye (Lond)       Date:  2022-09-10       Impact factor: 4.456

6.  Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.

Authors:  Mladen Bušić; Mirjana Bjeloš; Damir Bosnar; Senad Ramić; Iva Bušić
Journal:  Doc Ophthalmol       Date:  2016-01-23       Impact factor: 2.379

7.  Optical coherence tomography (OCT) features of cystoid spaces in choroideremia (CHM).

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Dario Giorgio; Andrea Sodi; Ilaria Passerini; Giacomo Bacci; Sara Bargiacchi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-26       Impact factor: 3.117

8.  ENHANCED S-CONE SYNDROME: VISUAL FUNCTION, CROSS-SECTIONAL IMAGING, AND CELLULAR STRUCTURE WITH ADAPTIVE OPTICS OPHTHALMOSCOPY.

Authors:  Michael J Ammar; Kurt T Scavelli; Katherine E Uyhazi; Emma C Bedoukian; Leona W Serrano; Ilaina D Edelstein; Grace Vergilio; Robert F Cooper; Jessica I W Morgan; Priyanka Kumar; Tomas S Aleman
Journal:  Retin Cases Brief Rep       Date:  2021-11-01

9.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

10.  Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy.

Authors:  Sibel Doguizi; Mehmet Ali Sekeroglu; Mustafa Alpaslan Anayol; Pelin Yilmazbas
Journal:  Case Rep Ophthalmol Med       Date:  2015-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.